ArticlebioRxiv : the preprint server for biology2025
Predicting Alzheimer's Disease Progression from Sparse Multimodal Data by NeuralODE Models.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Alzheimer's disease shows significantly variable progressions between patients, making early diagnosis, disease monitoring, and care planning difficult. Existing data-driven Disease Progression Models try to tackle this issue, but they usually require sufficiently large datasets of specific diagnostic modalities, which are rarely available in clinical practice. Here, we introduce a new modeling framework capable of predicting individual disease trajectories from sparse, irregularly sampled, multi-modal clinical data. Our method uses (recurrent) Neural Ordinary Differential Equations to determine the current hidden state of a patient from sparse past exams and to forecast future disease progression, illustrating how biomarkers evolve over time. When applied to the ADNI clinical cohort, the model detected early signs of disease more accurately than common data-driven alternatives and effectively tracked changes in biomarker trajectories that align with established clinical knowledge. This provides a versatile tool for accurate diagnosis and monitoring of neurodegenerative diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.